Expertise in
3
conditions

Silke Tribius

Asklepios Tumorzentrum
Hamburg, HH, DE 
Expertise in
3
conditions
Asklepios Tumorzentrum
Hamburg, HH, DE 

Overview

Silke Tribius practices practicing medicine in Hamburg, Germany.

Ms. Tribius is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Dry Mouth, Human Papillomavirus Infection, and Swallowing Difficulty.

She is actively involved in clinical research, co-authoring 71 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Asklepios Tumorzentrum
Hamburg, HH, Germany
Other Locations
Asklepios Hospital St. Georg, St. Georg, HH, Germany
Eppendorf, HH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Enrollment Status: Active_not_recruiting
Publish Date: August 14, 2026
Intervention Type: Radiation, Drug
Study Drugs: Durvalumab, 5-Fluorouracil, Mitomycin C
Study Phase: Phase 2
A Phase III Trial of Risk-stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
A Phase III Trial of Risk-stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 19, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 3
View 1 Less Clinical Trial

71 Total Publications

HPV-associated oropharyngeal carcinomas in the 9th edition of the TNM classification - Clinical classification and consequences
HPV-associated oropharyngeal carcinomas in the 9th edition of the TNM classification - Clinical classification and consequences
Journal: Laryngo- rhino- otologie
Published: September 03, 2026

Frequently Asked Questions about Silke Tribius

Is Silke Tribius a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Silke Tribius is classified as an Advanced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Silke Tribius participate in research or clinical trials?

Yes. Silke Tribius has published 71 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Silke Tribius's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Tribius's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile